Measures activity, not value. Not investment advice.
Net income jumped 66% to $3.8B in 12 months while the stock rose 41% over the year.
GoodInstitutional holders up 16% to 776 in the latest quarter
BadInsiders sold $40.8M in 90 days and bought nothing
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Industry
Services-general medical & surgical hospitals, nec (Health Care)
expected around 1 Feb 2027 (an estimate: a year ago it reported on 2 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $5.6B, net income $1.2B.
31 Dec 2021RevenueNet incometallest bar $5.6B30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$5.6B
$1.2B
30 Jun 2026
$5.6B
$1.0B
31 Mar 2026
$5.4B
$906.0M
31 Dec 2025
$5.5B
$644.0M
30 Sep 2025
$5.3B
$579.0M
30 Jun 2025
$5.3B
$522.0M
31 Mar 2025
$5.2B
$622.0M
31 Dec 2024
$5.1B
$572.0M
30 Sep 2024
$5.1B
$681.0M
30 Jun 2024
$5.1B
$477.0M
31 Mar 2024
$5.4B
$2.3B
31 Dec 2023
$5.4B
$456.0M
30 Sep 2023
$5.1B
$266.0M
30 Jun 2023
$5.1B
$293.0M
31 Mar 2023
$5.0B
$296.0M
31 Dec 2022
$5.0B
$274.0M
30 Sep 2022
$4.9B
$268.0M
30 Jun 2022
$4.7B
$179.0M
31 Mar 2022
$4.8B
$280.0M
31 Dec 2021
$5.0B
–
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$22.2B
$20.9B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+6.2%
+4.0%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$3.8B
$2.3B
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$34.47
$14.70
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
–
63.5%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
24.4%
16.7%
-9.1%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
17.2%
11.0%
5.1%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
80.7%
-44.4%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$3.3B
$1.5B
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$2.7B
$3.0B
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$13.2B
$13.2B
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$10.6B
$10.2B
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
2.4
0.06
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$68.40
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
5.5
7.1
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
0.95
0.75
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
1.4
1.1
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
3.8
2.2
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$40.8M
bought $0, sold $40.8M
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+16%
776 13F filers vs 667
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
92%
73.1M shares held by 13F filers (30 Sep 2026) of 79.6M outstanding (23 Oct 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
2.2%
1.8M shares sold short (30 Oct 2026) of 79.6M outstanding (23 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
2.2
1.8M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-3.3%
1.8M shares sold short in the report before, 1.8M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
50%
50% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 49%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
2,591
Tracked since 21 Nov 2026
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
Tracking started 21 Nov 2026; the change shows after 30 days.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+6.5%
$5.6B vs $5.3B (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
-29%
$198.0M vs $280.0M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
$1.0M
the 12 months before: $57K
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$4.8M
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
21
21 articles in the last 7 days; its usual week has 6 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
3.5×
21 articles in the last 7 days; its usual week has 6.
Price $263.19 on 20 Nov 2026, +41% over 12 months (12-month range $161.37 to $292.97)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders sold a net $63.2M in the last 12 months (the 12 months before: -$36.3M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 18 published in the last 12 months (none in the 12 months before).Revenue per quarter. Revenue $5.6B in the latest quarter, +6.5% on a year earlier.Capital spending per quarter. Capital spending $198.0M in the latest quarter, -29% on a year earlier.Institutional holders (13F filers). 776 13F filers reported holding it in the latest 13F quarter, +21% on a year earlier.Federal obligations. Federal obligations: $970K published in the last 12 months, +618% on the 12 months before.Lobbying spend. Lobbying spend: $4.8M published in the last 12 months, +38% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.
Quarter ended 31 Dec 2021: $5.0B, -6.8% on a year earlier; public on 19 Feb 2022
Quarter ended 31 Mar 2022: $4.8B, -1.3% on a year earlier; public on 30 Apr 2022
Quarter ended 30 Jun 2022: $4.7B, -4.8% on a year earlier; public on 30 Jul 2022
Quarter ended 30 Sep 2022: $4.9B, -0.9% on a year earlier; public on 29 Oct 2022
Quarter ended 31 Dec 2022: $5.0B, +0.7% on a year earlier; public on 22 Feb 2023
Quarter ended 31 Mar 2023: $5.0B, +5.7% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $5.1B, +7.6% on a year earlier; public on 1 Aug 2023
Quarter ended 30 Sep 2023: $5.1B, +4.4% on a year earlier; public on 31 Oct 2023
Quarter ended 31 Dec 2023: $5.4B, +7.0% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $5.4B, +6.8% on a year earlier; public on 1 May 2024
Quarter ended 30 Jun 2024: $5.1B, +0.4% on a year earlier; public on 31 Jul 2024
Quarter ended 30 Sep 2024: $5.1B, +1.1% on a year earlier; public on 30 Oct 2024
Quarter ended 31 Dec 2024: $5.1B, -5.7% on a year earlier; public on 19 Feb 2025
Quarter ended 31 Mar 2025: $5.2B, -2.7% on a year earlier; public on 30 Apr 2025
Quarter ended 30 Jun 2025: $5.3B, +3.2% on a year earlier; public on 31 Jul 2025
Quarter ended 30 Sep 2025: $5.3B, +3.2% on a year earlier; public on 29 Oct 2025
Quarter ended 31 Dec 2025: $5.5B, +8.9% on a year earlier; public on 18 Feb 2026
Quarter ended 31 Mar 2026: $5.4B, +2.8% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $5.6B, +6.8% on a year earlier; public on 30 Jul 2026
Quarter ended 30 Sep 2026: $5.6B, +6.5% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $304.0M, +83% on a year earlier; public on 19 Feb 2022
Quarter ended 31 Mar 2022: $155.0M, +28% on a year earlier; public on 30 Apr 2022
Quarter ended 30 Jun 2022: $152.0M, +25% on a year earlier; public on 30 Jul 2022
Quarter ended 30 Sep 2022: $165.0M, +49% on a year earlier; public on 29 Oct 2022
Quarter ended 31 Dec 2022: $290.0M, -4.6% on a year earlier; public on 22 Feb 2023
Quarter ended 31 Mar 2023: $235.0M, +52% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $132.0M, -13% on a year earlier; public on 1 Aug 2023
Quarter ended 30 Sep 2023: $176.0M, +6.7% on a year earlier; public on 31 Oct 2023
Quarter ended 31 Dec 2023: $208.0M, -28% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $240.0M, +2.1% on a year earlier; public on 1 May 2024
Quarter ended 30 Jun 2024: $145.0M, +9.8% on a year earlier; public on 31 Jul 2024
Quarter ended 30 Sep 2024: $216.0M, +23% on a year earlier; public on 30 Oct 2024
Quarter ended 31 Dec 2024: $330.0M, +59% on a year earlier; public on 19 Feb 2025
Quarter ended 31 Mar 2025: $173.0M, -28% on a year earlier; public on 30 Apr 2025
Quarter ended 30 Jun 2025: $193.0M, +33% on a year earlier; public on 31 Jul 2025
Quarter ended 30 Sep 2025: $280.0M, +30% on a year earlier; public on 29 Oct 2025
Quarter ended 31 Dec 2025: $364.0M, +10% on a year earlier; public on 18 Feb 2026
Quarter ended 31 Mar 2026: $180.0M, +4.0% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $168.0M, -13% on a year earlier; public on 30 Jul 2026
Quarter ended 30 Sep 2026: $198.0M, -29% on a year earlier; public on 30 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 344; public on 14 Feb 2022
31 Mar 2022 report: 388; public on 16 May 2022
30 Jun 2022 report: 355; public on 15 Aug 2022
30 Sep 2022 report: 338; public on 14 Nov 2022
31 Dec 2022 report: 327; public on 14 Feb 2023
31 Mar 2023 report: 342; public on 15 May 2023
30 Jun 2023 report: 394; public on 14 Aug 2023
30 Sep 2023 report: 374; public on 14 Nov 2023
31 Dec 2023 report: 395; public on 14 Feb 2024
31 Mar 2024 report: 428; public on 15 May 2024
30 Jun 2024 report: 501; public on 14 Aug 2024
30 Sep 2024 report: 569; public on 14 Nov 2024
31 Dec 2024 report: 555; public on 14 Feb 2025
31 Mar 2025 report: 536; public on 15 May 2025
30 Jun 2025 report: 598; public on 14 Aug 2025
30 Sep 2025 report: 643; public on 14 Nov 2025
31 Dec 2025 report: 671; public on 17 Feb 2026
31 Mar 2026 report: 675; public on 15 May 2026
30 Jun 2026 report: 667; public on 14 Aug 2026
30 Sep 2026 report: 776; public on 16 Nov 2026
Federal obligations
Month from 1 Jan 2022: $1.5M published
Month from 1 Feb 2022: $2.2M published
Month from 1 Apr 2022: $0 published
Month from 1 May 2022: $761K published
Month from 1 Jun 2022: $320K published
Month from 1 Jul 2022: $3.2M published
Month from 1 Aug 2022: $13K published
Month from 1 Sep 2022: $6.1M published
Month from 1 Oct 2022: $446K published
Month from 1 Nov 2022: -$78K published
Month from 1 Mar 2023: $50K published
Month from 1 Apr 2023: $30K published
Month from 1 May 2023: $48K published
Month from 1 Jun 2023: $412K published
Month from 1 Aug 2023: $246K published
Month from 1 Sep 2023: -$232K published
Month from 1 Oct 2023: -$90K published
Month from 1 Nov 2023: $0 published
Month from 1 Jan 2024: $36K published
Month from 1 Mar 2024: $30K published
Month from 1 Jul 2024: $270K published
Month from 1 Oct 2024: -$27K published
Month from 1 Jan 2025: $36K published
Month from 1 Feb 2025: -$9K published
Month from 1 Apr 2025: $0 published
Month from 1 Jul 2025: $30K published
Month from 1 Oct 2025: $90K published
Month from 1 Nov 2025: -$12K published
Month from 1 Feb 2026: $135K published
Month from 1 Jun 2026: $135K published
Month from 1 Jul 2026: $350K published
Month from 1 Aug 2026: $350K published
Month from 1 Oct 2026: $0 published
Lobbying spend
Quarter from 1 Jan 2022: $580K published
Quarter from 1 Apr 2022: $580K published
Quarter from 1 Jul 2022: $580K published
Quarter from 1 Oct 2022: $580K published
Quarter from 1 Jan 2023: $590K published
Quarter from 1 Apr 2023: $590K published
Quarter from 1 Jul 2023: $590K published
Quarter from 1 Oct 2023: $590K published
Quarter from 1 Jan 2024: $590K published
Quarter from 1 Apr 2024: $550K published
Quarter from 1 Jul 2024: $550K published
Quarter from 1 Oct 2024: $550K published
Quarter from 1 Jan 2025: $550K published
Quarter from 1 Apr 2025: $610K published
Quarter from 1 Jul 2025: $1.2M published
Quarter from 1 Oct 2025: $1.2M published
Quarter from 1 Jan 2026: $1.2M published
Quarter from 1 Apr 2026: $1.2M published
Quarter from 1 Jul 2026: $1.2M published
Quarter from 1 Oct 2026: $1.3M published
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is H-1B/E-3 applications certified at 4 (Aug 2026), 56% below its normal month of 9.
2,591 open postings; careers site tracked since 21 Nov 2026. Most in People & recruiting 2%, Operations & administration 2%, Research & science 1%, Nuclear fission & fusion 1%.
Reported lobbying spend: $1.3M in Q3 2026, $1.2M in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
1 Jul 2025
Ended
Northern Compass Group LLCfor Brownstein Hyatt Farber Schreck LLP Obo Tenet Business Services Corporation
Health Policy Source, Inc.for Conifer Health Solutions
Medicare and Medicaid medical debt-related issues, as well as associated transactional concerns involving payment, data, and quality metricsMedicare/Medicaid
Two or more unrelated kinds of records unusual within 30 days
18 May 2021confirmed
Confirmed across sources Institutional holdings and Lobbying
Tenet Healthcare Corporation New(THC): reported $780K of lobbying spend for the quarter ended 31 Mar 2021, 2.1× the same quarter last year, while it saw 60 13F filers open a new position in the quarter ended 31 Mar 2021, 1.3× the same quarter last year. Two unrelated kinds of activity within 28 days.
Lobbying: Lobbying spend jump, became public on 20 Apr 2021
Institutional holdings: Many funds opening a new position, became public on 17 May 2021
The quarter ended 31 Mar 2021 against the 8 quarters before it.
this quarterearliernormal: $365KSee the evidence (2 changes)
Lobbying: Lobbying spend jump became public on 20 Apr 2021
Tenet Healthcare Corporation New reported $780K of lobbying spend for the quarter ended 31 Mar 2021, 2.1× the same quarter last year.
This period
$780K (the quarter ended 31 Mar 2021)
Normal quarter (median of 8 earlier)
$365K
Typical spread (median absolute deviation)
$25K
How far from its usual level
+11.2
Same quarter last year
$380K
History used
3,835 days
the quarter ended 31 Mar 20218 earlier quartersnormal: $365K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Institutional holdings: Many funds opening a new position became public on 17 May 2021
Tenet Healthcare Corporation New saw 60 13F filers open a new position in the quarter ended 31 Mar 2021, 1.3× the same quarter last year.
This period
60 (the quarter ended 31 Mar 2021)
Normal quarter (median of 8 earlier)
36
Typical spread (median absolute deviation)
4
How far from its usual level
+4.0
Same quarter last year
45
History used
2,739 days
the quarter ended 31 Mar 20218 earlier quartersnormal: 36
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
16 Feb 2021confirmed
Confirmed across sources Institutional holdings and Lobbying
Tenet Healthcare Corporation New(THC): reported $580K of lobbying spend for the quarter ended 31 Dec 2020, 1.7× the same quarter last year, while it saw 51 13F filers open a new position in the quarter ended 31 Dec 2020, 1.9% below the same quarter last year. Two unrelated kinds of activity within 28 days.
Lobbying: Lobbying spend jump, became public on 19 Jan 2021
Institutional holdings: Many funds opening a new position, became public on 16 Feb 2021
The quarter ended 31 Dec 2020 against the 8 quarters before it.
this quarterearliernormal: $355KSee the evidence (2 changes)
Lobbying: Lobbying spend jump became public on 19 Jan 2021
Tenet Healthcare Corporation New reported $580K of lobbying spend for the quarter ended 31 Dec 2020, 1.7× the same quarter last year.
This period
$580K (the quarter ended 31 Dec 2020)
Normal quarter (median of 8 earlier)
$355K
Typical spread (median absolute deviation)
$15K
How far from its usual level
+6.3
Same quarter last year
$340K
History used
3,653 days
the quarter ended 31 Dec 20208 earlier quartersnormal: $355K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Institutional holdings: Many funds opening a new position became public on 16 Feb 2021
Tenet Healthcare Corporation New saw 51 13F filers open a new position in the quarter ended 31 Dec 2020, 1.9% below the same quarter last year.
This period
51 (the quarter ended 31 Dec 2020)
Normal quarter (median of 8 earlier)
34.5
Typical spread (median absolute deviation)
2.5
How far from its usual level
+4.5
Same quarter last year
52
History used
2,649 days
the quarter ended 31 Dec 20208 earlier quartersnormal: 34.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
21 Jul 2020confirmed
Confirmed across sources Layoff notices and Lobbying
Tenet Healthcare Corporation New(THC): filed a WARN layoff notice covering 34 workers within 30 days, while it reported $690K of lobbying spend for the quarter ended 30 Jun 2020, 2.0× the same quarter last year. Two unrelated kinds of activity on the same day.
Layoff notices: WARN layoff notice, became public on 21 Jul 2020
Lobbying: Lobbying spend jump, became public on 20 Jul 2020
The quarter ended 30 Jun 2020 against the 8 quarters before it.
this quarterearliernormal: $355KSee the evidence (2 changes)
Layoff notices: WARN layoff notice became public on 21 Jul 2020
Tenet Healthcare Corporation New filed a WARN layoff notice covering 34 workers within 30 days.
Fires on a WARN notice after 30 days without one; notices within 30 days are summed.
Lobbying: Lobbying spend jump became public on 20 Jul 2020
Tenet Healthcare Corporation New reported $690K of lobbying spend for the quarter ended 30 Jun 2020, 2.0× the same quarter last year.
This period
$690K (the quarter ended 30 Jun 2020)
Normal quarter (median of 8 earlier)
$355K
Typical spread (median absolute deviation)
$15K
How far from its usual level
+9.4
Same quarter last year
$350K
History used
3,379 days
the quarter ended 30 Jun 20208 earlier quartersnormal: $355K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
reported $1.2M of lobbying spend for the quarter ended 31 Dec 2025, 2.1× the same quarter last year.
Same quarter last year: $550K; its normal quarter is $570K.
See the evidence
This period
$1.2M (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
$570K
Typical spread (median absolute deviation)
$20K
How far from its usual level
+10.5
Same quarter last year
$550K
History used
6,301 days
the quarter ended 31 Dec 20258 earlier quartersnormal: $570K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
saw 111 13F filers open a new position in the quarter ended 30 Sep 2024, 3.3× the same quarter last year.
Same quarter last year: 34; its normal quarter is 52.
See the evidence
This period
111 (the quarter ended 30 Sep 2024)
Normal quarter (median of 8 earlier)
52
Typical spread (median absolute deviation)
10.5
How far from its usual level
+3.8
Same quarter last year
34
History used
4,018 days
the quarter ended 30 Sep 20248 earlier quartersnormal: 52
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
saw 98 13F filers open a new position in the quarter ended 30 Jun 2024, 1.1× the same quarter last year.
Same quarter last year: 88; its normal quarter is 48.5.
See the evidence
This period
98 (the quarter ended 30 Jun 2024)
Normal quarter (median of 8 earlier)
48.5
Typical spread (median absolute deviation)
5.5
How far from its usual level
+6.1
Same quarter last year
88
History used
3,926 days
the quarter ended 30 Jun 20248 earlier quartersnormal: 48.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
saw 88 13F filers open a new position in the quarter ended 30 Jun 2023, 1.8× the same quarter last year.
Same quarter last year: 49; its normal quarter is 50.
See the evidence
This period
88 (the quarter ended 30 Jun 2023)
Normal quarter (median of 8 earlier)
50
Typical spread (median absolute deviation)
4.5
How far from its usual level
+5.7
Same quarter last year
49
History used
3,560 days
the quarter ended 30 Jun 20238 earlier quartersnormal: 50
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
spent $304.0M on capital projects in the quarter ended 31 Dec 2021, 1.8× the same quarter last year.
Same quarter last year: $166.0M; its normal quarter is $121.5M.
See the evidence
This period
$304.0M (the quarter ended 31 Dec 2021)
Normal quarter (median of 8 earlier)
$121.5M
Typical spread (median absolute deviation)
$25.5M
How far from its usual level
+4.8
Same quarter last year
$166.0M
History used
3,287 days
the quarter ended 31 Dec 20218 earlier quartersnormal: $121.5M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
booked $6.3M in federal contract and grant obligations in July 2021, 33× the same month last year.
Same month last year: $194K; its normal month is $532K.
See the evidence
This period
$6.3M (July 2021)
Normal month (median of 5 earlier)
$532K
Typical spread (median absolute deviation)
$338K
How far from its usual level
+5.8
Same month last year
$194K
History used
4,743 days
July 20215 earlier monthsnormal: $532K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
reported $780K of lobbying spend for the quarter ended 31 Mar 2021, 2.1× the same quarter last year, while it saw 60 13F filers open a new position in the quarter ended 31 Mar 2021, 1.3× the same quarter last year. Two unrelated kinds of activity within 28 days.
See the evidence (2 changes)
Lobbying: Lobbying spend jump became public on 20 Apr 2021
Tenet Healthcare Corporation New reported $780K of lobbying spend for the quarter ended 31 Mar 2021, 2.1× the same quarter last year.
This period
$780K (the quarter ended 31 Mar 2021)
Normal quarter (median of 8 earlier)
$365K
Typical spread (median absolute deviation)
$25K
How far from its usual level
+11.2
Same quarter last year
$380K
History used
3,835 days
the quarter ended 31 Mar 20218 earlier quartersnormal: $365K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Institutional holdings: Many funds opening a new position became public on 17 May 2021
Tenet Healthcare Corporation New saw 60 13F filers open a new position in the quarter ended 31 Mar 2021, 1.3× the same quarter last year.
This period
60 (the quarter ended 31 Mar 2021)
Normal quarter (median of 8 earlier)
36
Typical spread (median absolute deviation)
4
How far from its usual level
+4.0
Same quarter last year
45
History used
2,739 days
the quarter ended 31 Mar 20218 earlier quartersnormal: 36
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
17 May 2021Institutional holdings change
saw 60 13F filers open a new position in the quarter ended 31 Mar 2021, 1.3× the same quarter last year.
Same quarter last year: 45; its normal quarter is 36.
See the evidence
This period
60 (the quarter ended 31 Mar 2021)
Normal quarter (median of 8 earlier)
36
Typical spread (median absolute deviation)
4
How far from its usual level
+4.0
Same quarter last year
45
History used
2,739 days
the quarter ended 31 Mar 20218 earlier quartersnormal: 36
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Showing the newest 40 of 153 entries; narrow the window or the kind of data to see older ones.
Not listed: 256 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0000070318
Ticker
THC
Domain
tenethealth.com
Employer name
BHS Physicians Network, Inc., Cardiology Physicians, LLC, Conifer Revenue Cycle Solutions, LLC, Desert Regional Medical Center and 7 more (11 unverified)
Fein
20-3059260, 27-3176652, 47-4291438, 51-0363108 and 7 more (11 unverified)
Hq location
TX|DALLAS|75254 (1 unverified)
Lobbying client
brownstein hyatt farber schreck llp obo tenet business services, conifer health solutions, conifer revenue cycle solutions llc a subsidiary of tenet healthcare, southwest orthopedic and spine hospital and 4 more
Name
601 N 30th Street III, Inc, 601 N 30th Street I, L.L.C, Advanced Ambulatory Surgical Care, L.P, Advanced Center for Surgery – Vero Beach, LLC and 1198 more